Robocath expects its R-One robotic-assistance platform to make interventional cardiology more efficient and safer for interventionalists.
Robocath initially began developing R-One to minimize interventionalists’ exposure to X-rays, which can increase their risk of cancer over time, Robocath CEO Lucien Goffart told Medtech Insight. R-One’s control console...